Jasco Pharmaceuticals Initiates a Collaborative Research Program in Pancreatic Cancer with North Carolina Central University
3/10/2011 8:10:11 AM
WOBURN, Mass.--(BUSINESS WIRE)--Jasco Pharmaceuticals, LLC has initiated a collaborative research program with North Carolina Central University (NCCU) in Durham, North Carolina, focused on developing therapeutics for pancreatic cancer that function through a Pim kinase mechanism of action. The research program will combine the biological platform, tools and expertise at NCCU in the laboratory of Professor Antonio T. Baines with Jasco Pharma’s proprietary selective Pim kinase inhibitors. Prof. Baines is a faculty member in the Department of Biology with a joint appointment in the Cancer Research Program of the Julius L. Chambers Biomedical/Biotechnology Research Institute at NCCU.
comments powered by